Rhythm Biotherapeutics
PrivateLast Round
Seed
Dec 5, 2025
Total Funding Raised
$4.31M
Company Overview
Rhythm Biotherapeutics Inc. is a biotechnology company developing exosome-based therapies to prevent and cure atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhythm Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Rhythm Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2025 | ||||
| Grant | Nov 15, 2024 | ||||
| Seed | Nov 15, 2024 |
Rhythm Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capital BioVentures | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 5, 2025
Raised $4M in seed funding.
- Nov 15, 2024
$235K round led by Ken Newport
Rhythm Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rhythm Biotherapeutics's valuation, stock price, and market status.
